Point of Care Imaging Can Speed Sight Saving Treatments for Patients

By StaffL
Tuesday, November 24, 2020 12:21 AM SOUTHAMPTON, U.K.—A new study led by the University of Southampton in the U.K. showed how simple, non-invasive imaging at the point of care can aid the diagnosis of corneal infections, reducing the risk of sight loss and helping a patient’s vision return to its pre-infection level.

Vision Innovation Partners Completes 16th Acquisition, Adds Leading Baltimore Area Practice to Mid-Atlantic Platform

By Staff
Wednesday, November 4, 2020 12:21 AM ANNAPOLIS, Md.—Omni Eye Specialists, one of the leading multi-specialty ophthalmology groups in the Baltimore metro area, has been acquired by Vision Innovation Partners, according to an announcement this week.

Retina Consultants of America Announces Alliance With Palmetto Retina Center

By Staff
Tuesday, November 3, 2020 12:30 AM SOUTHLAKE, Texas—Retina Consultants of America (RCA), a comprehensive physician management services organization that was formed by a private equity investor group earlier this year, has announced a new practice alliance with Palmetto Retina Center LLC, which is based in South Carolina. The move adds a seventh practice group to RCA’s “growing consortium of practices,” according to the announcement this week. The terms of the alliance transaction were not disclosed. Palmetto Retina Center is comprised of five retina specialists across six offices serving South Carolina.

PolyActiva Appoints Tracy Valorie, Former B+L Executive, to its Board

By Staff
Monday, November 2, 2020 12:18 AM MELBOURNE, Australia—PolyActiva, a clinical-stage ophthalmology biopharmaceutical company, has appointed Tracy Valorie, a highly experienced ophthalmic industry expert, as a new member to its board of directors.

Kala Pharmaceuticals Announces FDA Approval of Dry Eye Drug

By Staff
Friday, October 30, 2020 12:24 AM WATERTOWN, Mass.—Kala Pharmaceuticals (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, announced that the U.S. Food and Drug Administration (FDA) has approved Eysuvis (loteprednol etabonate ophthalmic suspension) 0.25% for the short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease.

Visus Therapeutics Expands Clinical Advisory Board With Appointment of Four Renowned Ophthalmologists

By Staff
Tuesday, October 27, 2020 12:21 AM SEATTLE—Visus Therapeutics Inc., a clinical-stage company working to develop the first presbyopia-correcting eye drop with the potential to last a minimum of eight hours, announced the appointments of three ophthalmologists Marguerite McDonald, MD, Neda Shamie, MD, William Trattler, MD, and Lawrence Woodard, MD, to its clinical advisory board.

Katena Products Acquires Micro-Select Instruments

By Staff
Monday, October 26, 2020 12:21 AM PARSIPPANY, N.J.—Katena Products, a leading global provider of precision ophthalmic instruments, biologics, and devices to hospitals, surgical centers, and ophthalmic and optometric offices announced its purchase of Micro-Select Instruments.

Azura Ophthalmics Raises $20 Million to Study Treatment of Leading Cause of Dry Eye Disease

By Staff
Monday, October 26, 2020 12:15 AM MELBOURNE, Australia and TEL AVIV, Israel—Azura Ophthalmics, a clinical-stage company developing innovative therapies for meibomian gland dysfunction (MGD) and related eye diseases, announced the completion of a $20 million fundraising round. The round included participation from existing investors, including Brandon Capital's Medical Research Commercialisation Fund (MRCF), OrbiMed, TPG Biotech and Ganot Capital.

BostonSight Collaborates With ECPs on Higher Order Aberration Correction Technology

By Staff
Thursday, October 22, 2020 12:18 AM NEEDHAM, Mass.—BostonSight, a nonprofit eye health care organization and research center dedicated to saving sight and improving quality of life, announced their HOA Collaborator Program, a partnership with eyecare professionals to offer SmartSight higher order aberration correction technology in specialty lenses.

Grand Rapids Ophthalmology’s Drive for Vision Golf Outing Raises $25,000 for Visually Impaired

By Staff
Monday, October 12, 2020 12:15 AM GRAND RAPIDS, Mich.—The 33rd Annual Grand Rapids Ophthalmology Drive for Vision charity golf outing, held on Sept. 21, raised more than $25,000 this year despite the challenges of the ongoing COVID-19 outbreak across the Midwest, according to a recent announcement. The event had been scheduled for June, but had to be postponed due to the restrictions in place for coronavirus control. Grand Rapids Ophthalmology, the largest fully integrated eyecare medical group in West Michigan, is a member of the Blue Sky Vision management organization.

Centricity Vision Appoints Jim Mazzo to its Board of Directors

By Staff
Monday, October 5, 2020 12:15 AM CARLSBAD, Calif.—Centricity Vision, a global ophthalmic technology company, announced that Jim Mazzo has been appointed to the company’s board of directors. Mazzo is one of the ophthalmic industry’s best known and most well respected business leaders with over 40 years of experience. His global reputation for building and running world-class organizations is based on 22 years leading Allergan’s North American and European eyecare organizations; seven years as Chairman, president and CEO of Advanced Medical Optics (AMO); four years as executive vice president of Abbott’s global ophthalmology business; three years as executive chair and CEO of AcuFocus and nearly four years as global president of ophthalmic devices for Carl Zeiss Meditec.

iViews and Oculo Partner to Enhance Clinical Collaboration and Improve Eyecare Models

By Staff
Wednesday, September 30, 2020 12:15 AM DUNEDIN, Fla.—iViews Imaging System and Oculo recently announced a North American partnership to bring an integrated solution to enhance clinical collaboration and improve models of eyecare. “We are delighted to work with the iViews team, who so clearly share Oculo’s passion to improve eyecare for patients by providing superior solutions for clinicians. Oculo will bring comprehensive teleophthalmology tools that enhance both the clinical practice and business performance for our optometry and ophthalmology customers,” said Dr. Kate Taylor, CEO and founder of Oculo.

Arkansas Supreme Court Denies Ballot Challenge to Scope of Practice Law

By Staff
Monday, September 21, 2020 12:30 AM LITTLE ROCK, Ark.—Optometrists in Arkansas had won the right to expand their scope of practice under a 2019 law, but these rights had been held in abeyance while an opposition group sought to have the law put to a vote in a state ballot referendum.

US Eye Network Expands in South Carolina Through Partnership With Carolina Eyecare Physicians

By Staff
Friday, September 18, 2020 12:33 AM CHARLESTON, S.C.—Carolina Eyecare Physicians, a leading multi-disciplinary physician group practicing in Carolina’s Lowcountry, has joined the expanding US Eye network of premium eyecare practices, according to an announcement Thursday. Carolina Eyecare Physicians will retain its existing practice name while integrating its operations, procedures and service offerings within the US Eye model, the announcement noted. The terms of the partnership deal were not disclosed.

Omni Group Partners With Eye Care Northwest

By Staff
Thursday, September 17, 2020 12:33 AM ISELIN, N.J. and SPARTA, N.J.— Omni Ophthalmic Management Consultants  (Omni), a portfolio company of NMS Capital (NMS), has announced a strategic partnership with Eye Care Northwest, P.A., a market-leading provider of medical-surgical eyecare services in northwest New Jersey. The terms of the transaction were not disclosed. Headquartered in Sparta, Eye Care Northwest has remained at the forefront of the eyecare field for more than 20 years and currently employs one board-certified ophthalmologist and one optometrist.